# Multi-Omics Noninvasive Inspection of TumOr Risk for Gastric Cancer

> **NCT04947995** · — · UNKNOWN · sponsor: **GeneCast Biotechnology Co., Ltd.** · enrollment: 450 (estimated)

## Conditions studied

- Gastric Cancer

## Interventions

- **DEVICE:** ctDNA multi-omics test

## Key facts

- **NCT ID:** NCT04947995
- **Lead sponsor:** GeneCast Biotechnology Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-06-15
- **Primary completion:** 2023-06-15
- **Final completion:** 2023-06-15
- **Target enrollment:** 450 (ESTIMATED)
- **Last updated:** 2021-07-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04947995

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04947995, "Multi-Omics Noninvasive Inspection of TumOr Risk for Gastric Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04947995. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*